Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy

… comparing outcomes of various treatment regimens in the search for the best-performing approach. … Challenges of …

When Perfect is the Enemy of Good: Investigators Compare Rigorous Clinical Trial Data to Real-World Experience

… Using a real-world cohort of US veterans, researchers examine the effectiveness of durvalumab …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

… of care and limited resources to review applications, researchers say they support the agency’s decision not to …

US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR

… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …

More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care

… oncological surgery. Finally, oncology is the most active research field globally. constantly evolving treatment methods … summary, because of significant progress in oncological research for NSCLC, and because surgery is an early and …

Antibody Drug Conjugates: Diamonds in the Rough?

… the blood brain barrier, underscoring the need for more research into this phenomenon All in all, the future looks … TPS ≥50%: phase 3 KEYNOTE-D46/EVOKE-03 study. Cancer Research. 2023;83(8_Supplement):CT067-CT067. …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

… immunotherapy and improved novel and targeted therapies. Research evaluating the survival benefit of early recurrence …

Artificial Intelligence in Thoracic Radiation Oncology: Treatment, Challenges, and Future Directions

… such as immunotherapy. Additionally, while prior AI research in radiation oncology has mostly focused on the …